E-mail Updates- Home
- Search for Research Summaries, Reviews, and Reports
EHC Component
- EPC Project
Related Products for this Topic
- Research Protocol May 7, 2010
- Disposition of Comments Report Oct. 7, 2011
- Clinician Summary Oct. 24, 2011
- Consumer Summary Oct. 24, 2011
- La Guías Sumaria de los Consumidores Jan. 17, 2012
- Executive Summary Jun. 13, 2011
Related Links for this Topic
Research Review - Final – Jun. 13, 2011 (Update)
Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update
Formats
- View PDF (PDF) 3.3 MB
- Web Version (NLM Site)
- Help with Viewers, Players, and Plug-ins
This report is an update to the original:
Matchar DB, McCrory DC, Orlando LA, et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Nov. (Comparative Effectiveness Reviews, No. 10.) AHRQ Publication No. 08-EHC003-EF.
Access the original report in HTML or PDF File (375 kb).
Matchar DB, McCrory DC, Orlando LA, et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Nov. (Comparative Effectiveness Reviews, No. 10.) AHRQ Publication No. 08-EHC003-EF.
Access the original report in HTML or PDF File (375 kb).
Persons using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us.
Return to Top of Page